IE44167B1 - Ophthalmic compositions - Google Patents

Ophthalmic compositions

Info

Publication number
IE44167B1
IE44167B1 IE2121/76A IE212176A IE44167B1 IE 44167 B1 IE44167 B1 IE 44167B1 IE 2121/76 A IE2121/76 A IE 2121/76A IE 212176 A IE212176 A IE 212176A IE 44167 B1 IE44167 B1 IE 44167B1
Authority
IE
Ireland
Prior art keywords
ophthalmic
butylamino
insert
hydrogen maleate
yloxy
Prior art date
Application number
IE2121/76A
Other languages
English (en)
Other versions
IE44167L (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IE44167L publication Critical patent/IE44167L/xx
Publication of IE44167B1 publication Critical patent/IE44167B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IE2121/76A 1975-09-26 1976-09-24 Ophthalmic compositions IE44167B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61711875A 1975-09-26 1975-09-26

Publications (2)

Publication Number Publication Date
IE44167L IE44167L (en) 1977-03-26
IE44167B1 true IE44167B1 (en) 1981-08-26

Family

ID=24472326

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2121/76A IE44167B1 (en) 1975-09-26 1976-09-24 Ophthalmic compositions

Country Status (12)

Country Link
AU (1) AU513280B2 (fr)
BE (1) BE846574A (fr)
CY (1) CY1023A (fr)
GB (1) GB1524405A (fr)
HK (1) HK67579A (fr)
IE (1) IE44167B1 (fr)
IL (1) IL50477A (fr)
KE (1) KE2990A (fr)
MY (1) MY8000138A (fr)
NZ (1) NZ182022A (fr)
PH (1) PH13467A (fr)
ZA (1) ZA765752B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
US4402976A (en) 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations

Also Published As

Publication number Publication date
AU513280B2 (en) 1980-11-27
GB1524405A (en) 1978-09-13
HK67579A (en) 1979-09-28
IE44167L (en) 1977-03-26
ZA765752B (en) 1978-05-30
NZ182022A (en) 1978-12-18
MY8000138A (en) 1980-12-31
CY1023A (en) 1980-08-01
IL50477A0 (en) 1976-11-30
PH13467A (en) 1980-05-15
KE2990A (en) 1979-09-28
AU1771476A (en) 1978-03-23
IL50477A (en) 1979-09-30
BE846574A (fr) 1977-03-24

Similar Documents

Publication Publication Date Title
US4195085A (en) Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
CA1184119A (fr) 2-benzothiazolesulfonamide hydroxyle, utile pour le traitement local de la pression intra-oculaire elevee
US4287175A (en) Contact lens wetting agents
US4551456A (en) Ophthalmic use of norfloxacin and related antibiotics
JPS6122975B2 (fr)
EP0033042A1 (fr) Inserts ophtalmiques d'inhibiteurs d'anhydrase carbonique pour l'application topique dans le traitement d'hypertension intraoculaire
US4045558A (en) Pilocarpine salts
US4402979A (en) Ophthalmic formulations of 5-fluoro-2-methyl-1-(p-methylthiobenzylidene)-3-indenylacetic acid
CA2218549C (fr) Procede d'augmentation du debit sanguin retinien
US4438123A (en) Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
US4542152A (en) 5-[Phenylsulfonyl(or sulfinyl)]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US5523301A (en) Optic nerve health
IE44167B1 (en) Ophthalmic compositions
EP0014642B1 (fr) Compositions ophtalmiques comprenant des combinaisons d'inhibiteurs d'anhydrase carbonique et de S-(-)-1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yl)-oxy-2-propanol pour application topique dans le traitement d'hypertension intraoculaire
EP0140789B1 (fr) Utilisation d'antagonistes de dopamine périphérique sélectifs pour la fabrication d'un médicament pour le traitement topique de l'hypertension oculaire
US4156010A (en) (R)-(-)-3-{[2-(P-hydroxyphenyl)-1-methylethyl]-aminomethyl}-3,4-dihydro-2H-1,5-benzodioxepin-3-ol
US4454148A (en) 5-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4312863A (en) Treatment of glaucoma
KR810001232B1 (ko) 안과용 조성물의 제조방법
US4774243A (en) Dopamine agonists for treating elevated intraocular pressure
US4510155A (en) 6(or 5)-Hydroxybenzothiazole-2-sulfonamide-O-sulfate salts for the topical treatment of elevated intraocular pressure
EP0034542A2 (fr) Pamoate de S-(-)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)-oxy)-2-propanol pour application locale dans le traitement de pression intraoculaire élevée
EP0036816B1 (fr) Composition ophtalmique à base d'acide 5-fluoro-2-méthyl-1-(p-méthylthio-benzylidène)-3-indénylacétique ou son sel
BG60332B2 (bg) Състав и методи за лечение на глаукома чрез локално приложение на т-бутиламино-3-(4-морфолино-1,2,5-тиадиазол-3-илокси)-2-пропанол хидроген малеат

Legal Events

Date Code Title Description
MK9A Patent expired